Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology

被引:47
作者
Espinar, Maria Jose [1 ,2 ]
Miranda, Isabel M. [1 ,3 ]
Costa-de-Oliveira, Sofia [1 ,3 ]
Rocha, Rita [1 ]
Rodrigues, Acacio G. [1 ,2 ]
Pina-Vaz, Cidalia [1 ,2 ,3 ]
机构
[1] Univ Porto, Fac Med, Dept Microbiol, P-4100 Oporto, Portugal
[2] Hosp Sao Joao, Dept Clin Pathol, Oporto, Portugal
[3] Univ Porto, CINTESIS Ctr Hlth Technol & Serv Res, Fac Med, P-4100 Oporto, Portugal
关键词
AMPLIFIED POLYMORPHIC DNA; INTENSIVE-CARE-UNIT; CTX-M ENZYMES; RENAL-TRANSPLANTATION; ANTIBIOTIC-RESISTANCE; ENTEROBACTERIACEAE; RECIPIENTS; COMMUNITY; RECURRENT; BACTEREMIA;
D O I
10.1371/journal.pone.0134737
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Urinary tract infection (UTI) is a common complication after kidney transplantation, often associated to graft loss and increased healthcare costs. Kidney transplant patients (KTPs) are particularly susceptible to infection by Enterobacteriaceae-producing extended-spectrum beta-lactamases (ESBLs). A retrospective case-control study was conducted to identify independent risk factors for ESBL-producing Escherichia coli and Klebsiella pneumoniae in non-hospitalized KTPs with UTI. Forty-nine patients suffering from UTI by ESBL-producing bacteria (ESBL-P) as case group and the same number of patients with UTI by ESBL negative (ESBL-N) as control-group were compared. Clinical data, renal function parameters during UTI episodes, UTI recurrence and relapsing rate, as well as risk factors for recurrence, molecular characterization of isolates and the respective antimicrobial susceptibility profile were evaluated. Diabetes mellitus (p <0.007), previous antibiotic prophylaxis (p=0.017) or therapy (p<0.001), previous UTI (p=0.01), relapsing infection (p=0.019) and patients with delayed graft function after transplant (p=0.001) represented risk factors for infection by ESBL positive Enterobacteriaceae in KTPs. Interestingly, the period of time between data of transplantation and data of UTI was shorter in case of ESBL-P case-group (28.8 months) compared with ESBL-N control-group (50.9 months). ESBL-producing bacteria exhibited higher resistance to fluoroquinolones (p=0.002), trimethoprim-sulfamethoxazole (p<0.001) and gentamicin (p<0.001). Molecular analysis showed that bla(CTX-M) was the most common ESBL encoding gene (65.3%), although in 55.1% of the cases more than one ESBL gene was found. In 29.4% of K. pneumoniae isolates, three bla-genes (bla(CTX-M)-bla(TEM)-bla(SHV)) were simultaneously detected. Low estimated glomerular filtration rate (p=0.009) was found to be risk factor for UTI recurrence. Over 60% of recurrent UTI episodes were caused by genetically similar strains. UTI by ESBL-producing
引用
收藏
页数:11
相关论文
共 50 条
[41]   Bacteremia caused by Escherichia coli and Klebsiella pneumoniae producing extended-spectrum betalactamases: Mortality and readmission-related factors [J].
Electra Perianes-Diaz, Maria ;
Novo-Veleiro, Ignacio ;
Solis-Diaz, Katia ;
Prolo-Acosta, Andrea ;
Garcia-Garcia, Inmaculada ;
Alonso-Claudio, Gloria .
MEDICINA CLINICA, 2014, 142 (09) :381-386
[42]   Phenotypic and genotypic detection of extended spectrum β-lactamases among Escherichia coli and Klebsiella pneumoniae isolates from type 2 diabetic patients with urinary tract infections [J].
Elmi, Souad Youssouf Kani ;
Ashour, Medhat Saber ;
Alsewy, Fathy Zakaria ;
Azzam, Nashwa Fawzy Abd El Moez .
AFRICAN HEALTH SCIENCES, 2021, 21 (02) :497-504
[43]   Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya [J].
Abujnah, Abubaker A. ;
Zorgani, Abdulaziz ;
Sabri, Mohamed A. M. ;
El-Mohammady, Hanan ;
Khalek, Rania A. ;
Ghenghesh, Khalifa S. .
LIBYAN JOURNAL OF MEDICINE, 2015, 10
[44]   Molecular Characterization and Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in the United Arab Emirates [J].
Alfaresi, Mubarak Saif ;
Elkoush, Abida A. ;
Alshehhi, Hajar M. ;
Abdulsalam, Adeel Islam .
MEDICAL PRINCIPLES AND PRACTICE, 2010, 20 (02) :177-180
[45]   Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase-Producing Escherichia coli Urinary Tract Infections in France [J].
Paumier, Adeline ;
Asquier-Khati, Antoine ;
Thibaut, Sonia ;
Coeffic, Thomas ;
Lemenand, Olivier ;
Larramendy, Stephanie ;
Leclere, Brice ;
Caillon, Jocelyne ;
Boutoille, David ;
Birgand, Gabriel .
JAMA NETWORK OPEN, 2022, 5 (09) :E2232679
[46]   Risk Factors for Multidrug Resistance in Nosocomial Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae [J].
Park, So Yeon ;
Kang, Cheol-In ;
Joo, Eun-Jeong ;
Ha, Young Eun ;
Wi, Yu Mi ;
Chung, Doo Ryeon ;
Peck, Kyong Ran ;
Lee, Nam-Yong ;
Song, Jae-Hoon .
MICROBIAL DRUG RESISTANCE, 2012, 18 (05) :518-524
[47]   Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection:: risk factors and clinical outcome [J].
Du, B ;
Long, Y ;
Liu, HZ ;
Chen, DC ;
Liu, DW ;
Xu, YC ;
Xie, XL .
INTENSIVE CARE MEDICINE, 2002, 28 (12) :1718-1723
[48]   Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli [J].
Cho, Sung-Yeon ;
Choi, Su-Mi ;
Park, Sun Hee ;
Lee, Dong-Gun ;
Choi, Jung-Hyun ;
Yoo, Jin-Hong .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (01) :156-161
[49]   MOLECULAR EPIDEMIOLOGY AND RISK FACTORS IN EXTENDED-SPECTRUM BETA LACTAMASE POSITIVE AND QUINOLONE-RESISTANT ESCHERICHIA COLI STRAINS ISOLATED FROM URINARY TRACT INFECTIONS [J].
Kilinc, Cetin ;
Inci, Melek ;
Yula, Erkan ;
Ozer, Burcin ;
Duran, Nizami ;
Durmaz, Suleyman ;
Kaya, Yusuf Selim ;
Inci, Mehmet .
ACTA MEDICA MEDITERRANEA, 2015, 31 (05) :1035-1039
[50]   Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated in selected hospitals of Anyigba, Nigeria [J].
Mofolorunsho, Kehinde C. ;
Ocheni, Hannah O. ;
Aminu, Ruth F. ;
Omatola, Cornelius A. ;
Olowonibi, Olabisi O. .
AFRICAN HEALTH SCIENCES, 2021, 21 (02) :505-512